Swedish Orphan Biovitrum income from continuous operations for the twelve months ending September 30, 2024 was $0.334B, a 25.44% increase year-over-year.
Swedish Orphan Biovitrum annual income from continuous operations for 2023 was $0.227B, a 13.14% decline from 2022.
Swedish Orphan Biovitrum annual income from continuous operations for 2022 was $0.261B, a 16.31% decline from 2021.
Swedish Orphan Biovitrum annual income from continuous operations for 2021 was $0.312B, a 11.69% decline from 2020.
Swedish Orphan Biovitrum Income from Continuous Operations 2019-2024 | BIOVF